How to buy Eli Lilly And Company shares in Australia

Our top picks for trading platforms

Global trading

FINDER AWARD

Moomoo Share Trading

Moomoo Share Trading

Trade ASX, US and Hong Kong stocks

GO TO SITE

Share trading carries risk, T&Cs apply

Copy trading

$150 REWARD

eToro

eToro

Social trading features

GO TO SITE

Share trading carries risk, T&Cs apply

Beginners

$120 REWARD

Tiger Brokers

Tiger Brokers

Easy-to-use mobile trading

GO TO SITE

Share trading carries risk, T&Cs apply

Compare trading platforms to buy Eli Lilly and Company shares

{"userFilters":[{"componentType":"MULTI-SELECT CHECKBOX","options":{"comparator":"contains","includeAllSelection":false,"defaultMatcher":"ANY","values":["8.95-10","6.95-8.94999","4.95-6.94999","0-4.94999"],"fields":[{"label":"[[FINDER_SCORE_BADGE|9+]] Excellent: 9+","value":"8.95-10","comparator":"range"},{"label":"[[FINDER_SCORE_BADGE|7+]] Great: 7+","value":"6.95-8.94999","comparator":"range"},{"label":"[[FINDER_SCORE_BADGE|5+]] Standard: 5+","value":"4.95-6.94999","comparator":"range"},{"label":"[[FINDER_SCORE_BADGE|0+]] Basic: 0+","value":"0-4.94999","comparator":"range"}]},"dataSelector":{"recordType":"PRODUCT","fieldCode":"FINDER_SCORE.FINDER_SCORE"},"dataType":"NUMBER","label":"Finder Score","queryParameter":"finderScore"},{"dataSelector":{"recordType":"UI_FILTER_COMPONENT","fieldCode":"SPECIAL_OFFERS"},"dataType":"BOOLEAN","label":"Special offers","componentType":"SpecialOffersFilter","config":{"VALUES":"1","fields":[{"value":"rewards_exclusive","label":"Finder Rewards & exclusives"},{"value":"all_offers","label":"All offers"}]},"options":{"comparator":"eq"}},{"config":{},"dataSelector":{"recordType":"product","fieldCode":"GENERAL.PROVIDER_ID"},"dataType":"UUID","label":"Provider","order":100},{"config":{"MULTISELECT":true,"VALUES":"Desktop,Android,iOS"},"dataSelector":{"recordType":"product","fieldCode":"FEATURES.AVAILABLE_DEVICES"},"dataType":"TEXT","label":"Available devices","order":null},{"config":{"MULTISELECT":true,"VALUES":"Australian stocks,US stocks,Global stocks,ASX Options,mFunds,ETFs,Bonds,Futures,US Options,Gold (physical),Silver (physical),Cryptocurrencies,Ready-made investment portfolios,Ethical portfolio option,Alternative investments,Commodities,NFTs,Endowment warrants,Installment warrants,Options trading,Commodity ETFs,ASX small cap stocks"},"dataSelector":{"recordType":"product","fieldCode":"FEATURES.AVAILABLE_PRODUCTS"},"dataType":"TEXT","label":"Products","order":null},{"config":{},"dataSelector":{"recordType":"product","fieldCode":"FEATURES.HAS_ONLINE_DEMO"},"dataType":"BOOLEAN","label":"Online Demo","order":null},{"config":{"MULTISELECT":true,"VALUES":"News,Technical analysis charts,Margin trading,Fractional shares"},"dataSelector":{"recordType":"product","fieldCode":"FEATURES.TRADING_TOOLS"},"dataType":"TEXT","label":"Trading tools","order":null},{"config":{},"dataSelector":{"recordType":"product","fieldCode":"FEES.INACTIVE_ACCOUNT_FEE"},"dataType":"BOOLEAN","label":"Inactivity fee","order":null},{"config":{"VALUES":"0"},"dataSelector":{"recordType":"UI_FILTER_COMPONENT","fieldCode":"FULL_MARKET"},"dataType":"FULL_MARKET","label":"More products"}],"niche":{"currencySymbol":"$","decimalPoint":".","decimalPlaces":"2","thousandsSeparator":",","filterBoundsMap":{"product.GENERAL.PROVIDER_ID":null,"product.FEATURES.AVAILABLE_DEVICES":null,"product.FEATURES.AVAILABLE_PRODUCTS":null,"product.FEATURES.HAS_ONLINE_DEMO":null,"product.FEATURES.TRADING_TOOLS":null,"product.FEES.INACTIVE_ACCOUNT_FEE":null}},"prefilled":false,"experimental":false}

6 of 27 results

Updated regularlyShare

Finder Score	AU Trading Fee	US Trading Fee	Asset Class
Promoted Finder Score 9.6 Excellent Moomoo Share Trading Finder Award	Finder Score 9.6 Excellent	$3.00	US$0.99	ASX shares,Global shares,Options trading,US shares,ETFs	Trade major markets with built-in social trading tools.	Go to siteView details Compare product selection Compare	loading
Promoted Finder Score 8.7 Great eToro	Finder Score 8.7 Great	US$2.00	US$2.00	ASX shares,Global shares,US shares,ETFs,Cryptocurrencies	CFD service. Capital at risk. Trade a range of assets from a single account with access to social trading features.	$150 REWARD Go to siteView details Compare product selection Compare	loading
Promoted Finder Score 9.8 Excellent Webull Finder Award	Finder Score 9.8 Excellent	$1.00	$0.00	ASX shares,Global shares,Options trading,US shares,ETFs,Cryptocurrencies	Welcome offer: Receive 5 US fractional shares by depositing or transferring AUD$500 or more into a new account. 2% cashback is also available to those who provide additional funding and execute a trade in the US market. Expires on 30 June. T&Cs apply.	Invest in over 15,000 shares, options, and $0 Brokerage on all U.S. and Australian Chess-Sponsored ETFs.	Go to siteView details Compare product selection Compare	loading
Finder Score 9.3 Excellent Tiger Brokers Finder Award	Finder Score 9.3 Excellent	$3.00	US$2.00	ASX shares,Global shares,Options trading,US shares,ETFs	Deposit any amount and receive $20 to trade in Tiger Brokers. Plus 4x zero brokerage trades and no FX fees on the first $2,000 you exchange every month. T&Cs apply.	Trade US, Asian and CHESS-sponsored ASX stocks, China A-class shares, plus US and Hong Kong options and ETFs.	$120 REWARD Go to siteView details Compare product selection Compare	loading
Finder Score 9.9 Excellent CMC Invest Finder Award	Finder Score 9.9 Excellent	$0.00	$0.00	ASX shares,Global shares,Options trading,US shares,mFunds,ETFs,Cryptocurrencies	Trade 45,000+ listed securities across the local markets and 15 major global exchanges.	Go to siteView details Compare product selection Compare	loading
Finder Score 9.3 Excellent IG Share Trading Finder Award	Finder Score 9.3 Excellent	$0.00	US$0.00	ASX shares,Global shares,US shares,UK shares,ETFs	Go to siteView details Compare product selection Compare	loading

loading

Load More

Showing 6 of 6 results

Compare other products

We currently don't have that product, but here are others to consider:

How we picked these

Finder Score for share trading platforms

We've scored over 30 share trading platforms assessing them for their core features, fees, customer experience and accessibility. Our experts give each platform a score out of 10.

Read the full methodology

Eli Lilly and Company overview

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, such as Cyramza for the second-line treatment of gastric cancer or gastro-esophageal junction adenocarcinoma; Erbitux for colorectal cancers and head and neck cancers; Inluriyo for breast cancer; Jaypirca for chronic lymphocytic leukemia or small lymphocytic lymphoma; Retevmo for the treatment of metastatic NSCLC; TYVYT for classic hodgkin's lymphoma; and Verzenio for breast cancer. In addition, the company offers immunology products, which include Ebglyss for severe atopic dermatitis; Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Omvoh for ulcerative colitis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. Further, it provides Emgality for migraine prevention and episodic cluster headache, as well as Kisubla for symptomatic Alzheimer's disease. The company has collaborations with Boehringer Ingelheim Pharmaceuticals, Inc. for the Jardiance product family; and F. Hoffmann-La Roche Ltd and Genentech, Inc. for lebrikizumab, as well as license agreements with Almirall, S.A. for Ebglyss; and Chugai Pharmaceutical Co., Ltd for orforglipron. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Is it a good time to buy Eli Lilly and Company stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Eli Lilly and Company share price volatility

Over the last 12 months, Eli Lilly and Company's shares have ranged in value from as little as US$620.4646 up to US$1132.0606. A popular way to gauge a stock's volatility is its "beta".

Beta measures a share's volatility in relation to the market. The market ( average) beta is 1, while Eli Lilly and Company's is 0.481. This would suggest that Eli Lilly and Company's shares are less volatile than average (for this exchange).

Eli Lilly and Company financials

TTM: trailing 12 months

Eli Lilly and Company share dividends

Dividend payout ratio: 21.96% of net profits

Recently Eli Lilly and Company has paid out, on average, around 21.96% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.7% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Eli Lilly and Company shareholders could enjoy a 0.7% return on their shares, in the form of dividend payments. In Eli Lilly and Company's case, that would currently equate to about 6.23 per share.

While Eli Lilly and Company's payout ratio might seem low, this can signify that Eli Lilly and Company is investing more in its future growth.

Eli Lilly and Company's next dividend payout is expected around 9 June 2026. To benefit from it's next dividend payout, you'll need to buy Eli Lilly and Company shares before 14 May 2026 (the "ex-dividend date").

Have Eli Lilly and Company's shares ever split?

Eli Lilly and Company's shares were split on a 2:1 basis on 15 October 1997. So if you had owned 1 share the day before the split, the next day you would own 2 shares. This wouldn't directly have changed the overall worth of your Eli Lilly and Company shares - just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Eli Lilly and Company shares which in turn could have impacted Eli Lilly and Company's share price.

Frequently asked questions

• What percentage of Eli Lilly and Company is owned by insiders or institutions?

  Currently 0.171% of Eli Lilly and Company shares are held by insiders and 91.608% by institutions.

• When does the fiscal year end for Eli Lilly and Company?

  Eli Lilly and Company's fiscal year ends in December.

• Where is Eli Lilly and Company based?

  Eli Lilly and Company's address is: Lilly Corporate Center, Indianapolis, IN, United States, 46285

• What is Eli Lilly and Company's ISIN number?

  Eli Lilly and Company's international securities identification number is: US5324571083

• What is Eli Lilly and Company's CUSIP number?

  Eli Lilly and Company's Committee on Uniform Securities Identification Procedures number is: 532457108